LP

Lokesh Pahariya

Active Director Director DIN 08979394
DIN 08979394 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Lokesh Pahariya

Data last updated:

Lokesh Pahariya is a Director at Rosecure Pharma Private Limited (since 2020). The company operates in Pharma. Rosecure Pharma Private Limited reported revenue of ₹2.99 Cr (FY 2025).

DIN 08979394
Primary Designation Director
Industry Pharma
First Appointment 30 Nov 2020
Oldest Company Age 9 yrs
Largest company Rosecure Pharma Private Limited · ₹2.99 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rosecure Pharma Private Limited U74999UP2017PTC094530
Director30 Nov 20202017₹2.99 Cr (FY 2025)Active

Board colleagues of Lokesh Pahariya

Directorship timeline

Open interactive timeline →
Rosecure Pharma Private Limited
Premium access

Shareholding and investment profile for Lokesh Pahariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lokesh Pahariya

Lokesh Pahariya currently holds 1 directorship: Rosecure Pharma Private Limited (Director, since 30 Nov 2020, revenue ₹2.99 Cr (FY 2025)).

Lokesh Pahariya was first appointed on 30 Nov 2020 as Director at Rosecure Pharma Private Limited.

The current boards of Lokesh Pahariya's companies include Abhishek Kumar Pahariya (Rosecure Pharma Private Limited), Deepesh Pahariya (Rosecure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available